Acrizanib, also known as LHA510, is a potent and selective angiogenesis inhibitor and VEGFR‑2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration.
MedKoo Cat#: 206780
Name: Acrizanib
CAS#: 1229453-99-9 (free base)
Chemical Formula: C20H18F3N7O2
Exact Mass: 445.1474
Molecular Weight: 445.41
Elemental Analysis: C, 53.93; H, 4.07; F, 12.80; N, 22.01; O, 7.18
The following data is based on the product molecular weight 445.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
